NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Jubilant Ingrevia Limited (NSE: JUBLINGREA)
JUBLINGREA Technical Analysis
5
As on 18th Apr 2024 JUBLINGREA SHARE Price closed @ 531.20 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 453.34 & Strong Buy for SHORT-TERM with Stoploss of 469.05 we also expect STOCK to react on Following IMPORTANT LEVELS. |
JUBLINGREASHARE Price
Open | 540.00 | Change | Price | % |
High | 549.30 | 1 Day | -7.20 | -1.34 |
Low | 526.25 | 1 Week | -12.60 | -2.32 |
Close | 531.20 | 1 Month | 91.20 | 20.73 |
Volume | 453697 | 1 Year | 124.95 | 30.76 |
52 Week High 582.95 | 52 Week Low 358.50 |
NSE INDIA Most Active Stocks
IDEA | 13.20 | 1.93% |
YESBANK | 23.90 | -0.21% |
TATASTEEL | 160.05 | 0.00% |
POWERGRID | 280.10 | 2.13% |
DHANI | 51.45 | 7.19% |
NHPC | 89.50 | -1.86% |
EXIDEIND | 449.65 | -2.21% |
GTLINFRA | 1.75 | 2.94% |
INDUSTOWER | 344.40 | 3.58% |
PNB | 129.55 | 0.78% |
NSE INDIA Top Gainers Stocks
KMSUGAR | 36.05 | 19.97% |
JUSTDIAL | 1009.35 | 13.27% |
ORICONENT | 43.40 | 12.87% |
SOLARA | 473.80 | 11.97% |
TPLPLASTEH | 84.25 | 11.29% |
ELIN | 164.05 | 10.58% |
ELIN | 164.05 | 10.58% |
DSSL | 1248.65 | 10.31% |
INDOTECH | 1575.40 | 10.00% |
ESSARSHPNG | 31.35 | 10.00% |
NSE INDIA Top Losers Stocks
STLTECH | 129.95 | -8.65% |
SADBHAV | 29.55 | -8.51% |
COFFEEDAY | 64.70 | -7.70% |
BHAGERIA | 172.70 | -6.88% |
GODHA | 0.70 | -6.67% |
HINDMOTORS | 20.50 | -6.61% |
TIRUPATIFL | 17.90 | -6.04% |
GAYAHWS | 0.85 | -5.56% |
IGL | 437.30 | -5.49% |
IGL | 437.30 | -5.49% |
JUBLINGREA Daily Charts |
JUBLINGREA Intraday Charts |
Whats New @ Bazaartrend |
JUBLINGREA Free Analysis |
|
JUBLINGREA Important Levels Intraday
RESISTANCE | 575.62 |
RESISTANCE | 561.37 |
RESISTANCE | 552.57 |
RESISTANCE | 543.76 |
SUPPORT | 518.64 |
SUPPORT | 509.83 |
SUPPORT | 501.03 |
SUPPORT | 486.78 |
JUBLINGREA Target April 2024
4th UP Target | 647.23 |
3rd UP Target | 592.84 |
2nd UP Target | 559.23 |
1st UP Target | 525.61 |
1st DOWN Target | 429.69 |
2nd DOWN Target | 396.07 |
3rd DOWN Target | 362.46 |
4th DOWN Target | 308.07 |
JUBLINGREA Weekly Target
4th UP Target | 774.23 |
3rd UP Target | 702.91 |
2nd UP Target | 658.83 |
1st UP Target | 614.74 |
1st DOWN Target | 488.96 |
2nd DOWN Target | 444.87 |
3rd DOWN Target | 400.79 |
4th DOWN Target | 329.47 |
JUBLINGREA Target2024
4th UP Target | 975.22 |
3rd UP Target | 825.57 |
2nd UP Target | 733.07 |
1st UP Target | 640.57 |
1st DOWN Target | 376.63 |
2nd DOWN Target | 284.13 |
3rd DOWN Target | 191.63 |
4th DOWN Target | 41.98 |
Jubilant Ingrevia Limited ( NSE INDIA Symbol : JUBLINGREA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
JUBLINGREA Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
JUBLINGREA Other Details
Segment | EQ | |
Market Capital | 108693356544.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
JUBLINGREA Address
JUBLINGREA Latest News
JUBLINGREA Business Profile
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment offers specialty ingredients, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Life Science Chemicals offers life science ingredients and specialty ethanol. The company also offers pyridine and picolines, cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines, vitamin B3 and picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, absolute alcohol, ethanol, biocompost, CO2 and ETO mixtures. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and based in Noida, India. Address: 1A, Sector 16A, Noida, India, 201301
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service